SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Mathematical modelling for antibiotic resistance control policy: do we know enough?

Knight, GM; Davies, NG; Colijn, C; Coll, F; Donker, T; Gifford, DR; Glover, RE; Jit, M; Klemm, E; Lehtinen, S; et al. Knight, GM; Davies, NG; Colijn, C; Coll, F; Donker, T; Gifford, DR; Glover, RE; Jit, M; Klemm, E; Lehtinen, S; Lindsay, JA; Lipsitch, M; Llewelyn, MJ; Mateus, ALP; Robotham, JV; Sharland, M; Stekel, D; Yakob, L; Atkins, KE (2019) Mathematical modelling for antibiotic resistance control policy: do we know enough? BMC Infect Dis, 19 (1). p. 1011. ISSN 1471-2334 https://doi.org/10.1186/s12879-019-4630-y
SGUL Authors: Sharland, Michael Roy

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (610kB) | Preview

Abstract

BACKGROUND: Antibiotics remain the cornerstone of modern medicine. Yet there exists an inherent dilemma in their use: we are able to prevent harm by administering antibiotic treatment as necessary to both humans and animals, but we must be mindful of limiting the spread of resistance and safeguarding the efficacy of antibiotics for current and future generations. Policies that strike the right balance must be informed by a transparent rationale that relies on a robust evidence base. MAIN TEXT: One way to generate the evidence base needed to inform policies for managing antibiotic resistance is by using mathematical models. These models can distil the key drivers of the dynamics of resistance transmission from complex infection and evolutionary processes, as well as predict likely responses to policy change in silico. Here, we ask whether we know enough about antibiotic resistance for mathematical modelling to robustly and effectively inform policy. We consider in turn the challenges associated with capturing antibiotic resistance evolution using mathematical models, and with translating mathematical modelling evidence into policy. CONCLUSIONS: We suggest that in spite of promising advances, we lack a complete understanding of key principles. From this we advocate for priority areas of future empirical and theoretical research.

Item Type: Article
Additional Information: © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Antibiotic resistance (ABR), Antimicrobial resistance (AMR), Decision-making, Dynamic modelling, 0605 Microbiology, 1103 Clinical Sciences, 1108 Medical Microbiology, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: BMC Infect Dis
ISSN: 1471-2334
Language: eng
Dates:
DateEvent
29 November 2019Published
11 November 2019Accepted
Projects:
Project IDFunderFunder ID
UNSPECIFIEDThe AMR Centre, LSHTMUNSPECIFIED
UNSPECIFIEDCentre for the Mathematical Modelling of Infectious Diseases, LSHTMUNSPECIFIED
PubMed ID: 31783803
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/111467
Publisher's version: https://doi.org/10.1186/s12879-019-4630-y

Actions (login required)

Edit Item Edit Item